Table: begin end state 1 60 non-cytoplasmic 61 81 transmembrane 82 107 cytoplasmic 108 133 transmembrane 134 150 non-cytoplasmic 151 172 transmembrane 173 181 cytoplasmic 182 202 transmembrane 203 229 non-cytoplasmic 230 250 transmembrane 251 263 cytoplasmic 264 289 transmembrane 290 303 non-cytoplasmic 304 325 transmembrane 326 345 cytoplasmic 346 367 transmembrane 368 372 non-cytoplasmic 373 394 transmembrane 395 413 cytoplasmic 414 432 transmembrane 433 436 non-cytoplasmic 437 455 transmembrane 456 480 cytoplasmic
Input: >Echvi_1617 FitnessBrowser__Cola:Echvi_1617 MSDKKNLVQKLESVNEYEREAIPQNKLKSWKSFVGTYAGEHTAGTEFVLGPLFVAHGASA VDLVSGLLVGNILAVLSWAFFTGKAATKTRHTLYFQLEKIAGSRFTMIYNLVNAVAFCFL AGAMITVAATAVGIPFDLAMPALDDTLPTSLGFVLTVFVVGAITTVIAMFGFNQVVKFAN IAAPWMIMIFVAAAVAVLPRLGINSIGDFWPVAKETIWSGVPLEGKTKFTFWHIMFFAWF CNMAMHIGMADMSILRYAKKWTAGFATSTGVFLGHYVAWIASGILYSLFLLESDGSLVFA PGPIAYEAVGIAGAICVIIAGWTTANPTLYRAGLAIQSINPNWKTWKVTLFVGLITTIAA CFPALMMQLLDFVALYGLVLMPLGAVIFIDIFLFPKMGMQSNFAALTHRNFNPAVGITWL ITLIFCLGLNLFAGVEIFFLGLPGWFVAVLVYIASSKIVQKNTSIPHTAKPNAKSEVPAS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server